Home » Baxter Reveals Results From Combined IMPENDIA/EDEN Trials
Baxter Reveals Results From Combined IMPENDIA/EDEN Trials
Baxter International said results from two large, international multicenter trials demonstrated that a low glucose peritoneal dialysis, or PD, regimen favorably impacted metabolic measures important for end-stage renal disease patients with diabetes, including blood glucose control and selected lipids.
RTT News
RTT News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May